Sign in

CIK 0001175151

  • Non-accelerated filer
  • Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980373793
Phone
+1 973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
Open-market buys, last 90 days
$120,435
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-08-08 Deliargyris Efthymios Chief Medical Officer Grant or award +70,000 473,025
2025-08-08 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (Right to Buy) +95,000 95,000
2025-01-17 Deliargyris Efthymios Chief Medical Officer Option exercise +16,233 $1.00 $16K 403,025
2025-01-17 Deliargyris Efthymios Chief Medical Officer Option exercise · Subscription Rights (right to buy) −16,233 0
2025-01-17 Deliargyris Efthymios Chief Medical Officer Other acquisition · Series A Right Warrants +16,233 16,233
2025-01-17 Deliargyris Efthymios Chief Medical Officer Other acquisition · Series B Right Warrants +16,233 16,233
2024-10-04 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-10-04 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2024-04-02 Deliargyris Efthymios Chief Medical Officer Grant or award +61,000 409,433
2024-04-02 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (Right to Buy) +86,000 86,000
2024-03-29 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (Right to Buy) +47,088 47,088
2023-12-13 Deliargyris Efthymios Chief Medical Officer Purchase +22,557 $1.33 $30K 348,433
2023-12-13 Deliargyris Efthymios Chief Medical Officer Purchase · Common Stock Warrant (Right to Buy) +7,894 7,894
2023-07-07 Deliargyris Efthymios Chief Medical Officer Grant or award +55,000 331,648
2023-07-07 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (right to buy) +78,000 78,000
2023-07-07 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (right to buy) +40,000 40,000
2022-08-10 Deliargyris Efthymios Chief Medical Officer Grant or award +55,000 228,384
2022-08-10 Deliargyris Efthymios Chief Medical Officer Grant or award +52,000 283,384
2022-08-10 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (right to buy) +74,000 74,000
2022-08-10 Deliargyris Efthymios Chief Medical Officer Grant or award · Stock Option (right to buy) +300,000 300,000

Page 1 of 2 · 24 trades